Evidation Research
Research
We perform research to help create actionable evidence in three key areas:
March 31, 2022
Dyslipidemia / High Cholesterol: PGHD delivers valuable insights for cholesterol management
Rapid Insights
- Quickly engage cohorts of individuals. Build your cohort based on therapeutic areas and demographics.
- Using data from wearable devices, capture near real-time measurements about an individual’s lived experience—like their activity and how they use devices.
- Correlate the data to key events.
Objective
Identify and segment patients based on real world behaviors and disease impact.
Value Delivered
Identify and segment patients based on real world behaviors and disease impact.
talk to our team View case study
May 1, 2022
Asthma — PGHD delivers a roadmap to optimal treatment
Patient Segmentation and Identification
- Identify and describe target patients based on real world behaviors and disease impact
- Quantify how disease impacts an individual’s quality of life and activities of daily living.
Objective
Identify and segment patients based on real world behaviors and disease impact.
Value Delivered
Identify and segment patients based on real world behaviors and disease impact.
talk to our team View case study
March 4, 2022
Alzheimers Disease and MCI — Cognitive impairment & PGHD: Insights for better management
Disease Event and Prevention Modeling
- Detect, describe, and predict disease events and changes in health status
- Measure disease progression and recovery over time
Objective
Identify and segment patients based on real world behaviors and disease impact.
Value Delivered
Identify and segment patients based on real world behaviors and disease impact.
talk to our team View case study
Recent Research and Publications
Stay up to date with our latest research on health outside clinic walls.
[May 27, 2026
ISPOR 2026 Recap: Understanding Health Between Visits \
Evidation’s research at ISPOR 2026 highlighted the growing need for direct, longitudinal patient data to better understand real-world outcomes
\
[December 4, 2025
Building with Patients: A Conversation with Rachel Sha, CEO of Vaxess Technologies \
Vaxess Technologies CEO Rachel Sha shares how patient voices are driving new delivery solutions for anti-obesity medications, with the potential to dramatically expand access and improve adherence.\ \
[October 16, 2025
How Evidation is Reshaping Substance Use Disorder (SUD) Research \
Evidation is developing a digital experience within the Evidation app, that will engage and educate individuals with SUD while collecting data to support the research and development needs of organizations developing treatments for SUD. \ \